Somerville, MA, United States of America

Megan Alene Cloonan Foley

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Megan Alene Cloonan Foley in Cancer Treatment

Introduction

Megan Alene Cloonan Foley is an accomplished inventor based in Somerville, MA. With a robust portfolio of seven patents, he has significantly contributed to the field of pharmaceutical research, particularly in cancer treatment. His advancements in medicinal chemistry are paving the way for innovative therapies against various diseases.

Latest Patents

Megan's latest patents showcase his focus on developing novel compounds aimed at treating serious medical conditions. One such patent is for "Substituted indoles and methods of use thereof," which includes compounds designed to treat cancer and other disorders. Another notable patent, "Isoxazole carboxamides as irreversible SMYD inhibitors," emphasizes his approach in targeting SMYD proteins, proving useful in cancer treatment. These innovative compounds provide new avenues for therapeutic interventions that can potentially save lives.

Career Highlights

Megan is currently employed at Epizyme, Inc., a company dedicated to delivering innovative cancer therapies. His work at Epizyme has solidified his reputation as a leading inventor in oncology-focused research. His patents not only represent a culmination of his research efforts but also highlight the importance of his contributions to advancing medicinal treatments in the pharmaceutical industry.

Collaborations

Throughout his career, Megan has collaborated with talented colleagues such as Lorna Helen Mitchell and Kevin Wayne Kuntz. These collaborations have fostered a creative environment that drives innovation and leads to breakthroughs in therapeutic development. Together, they have worked on several projects that explore the potential of new compounds in treating complex diseases.

Conclusion

Megan Alene Cloonan Foley's contributions to the field of pharmaceuticals, particularly in cancer research, underscore his status as a prominent inventor. Through his innovative patents and collaborative efforts, he continues to push the boundaries of science and medicine. As the landscape of cancer therapies evolves, the impact of Megan's work is poised to play a critical role in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…